Customer Testimonial Micromon Genomics

MGI, a division of global genomics leader BGI Group, announced in Oct. 2019 that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. Monash University's Micromon Genomics, a next-generation sequencing facility located in the university’s Biomedical precinct at the Clayton campus in Melbourne, provides sequencing services to Australian researchers, including DNA, RNA, single cell and customised applications. "This instrument precisely fits our yield requirements, giving us the flexibility and scope to complete both small and large projects, without the necessity to queue large numbers of samples before commencing sequencing runs,” Micromon Genomics’ NGS Manager Mr. Scott Coutts said. "Data quality is equal to or better than the data we currently generate on alternative platforms, as well as bringing about substantial service price reductions." The MGISEQ-2000 sequencer is a comprehensive and flexible production-scale sequencer that supports a range of applications in research, clinical use, forensics and agriculture. It can produce 18.75～1080 Gb per run with a number of read length options, such as SE50, SE100, PE100 and PE150. It takes 48 hours to sequence a PE100 run at full capacity, and less than three days to sequence PE150 at full capacity. Based on MGI’s proprietary core technology DNBSEQTM, MGISEQ-2000 supports multi-sequencing modes with increased accuracy, decreased duplicates and reduced index hopping. The innovative optical and biochemical system also enables completion of the entire sequencing process within a short period of time.